Skip to main content
NCBI home page
Infectious Diseases in Obstetrics and Gynecology logoLink to Infectious Diseases in Obstetrics and Gynecology
. 1996;4(1):7–15. doi: 10.1155/S1064744996000038

Cervical Antibodies to Herpes Simplex Virus Proteins in Pregnancy and Puerperium: A Pilot Study

D Heather Watts 1,✉, Jeanne-Marie Guise 1,5, Zane Brown 1, Lawrence Corey 2,3, Rhoda L Ashley 2,4
PMCID: PMC2364456  PMID: 18476057

Abstract

Objective: This study was undertaken to evaluate the changes in total and anti-herpes simplex virus (HSV)-specific cervical IgA and IgG antibody profiles during and after pregnancy.

Methods: Serum and cervical secretions were obtained from pregnant patients before 20 weeks gestation, at 34–36 weeks gestation, and at 6 weeks postpartum and tested for total IgA and IgG antibody and for IgA and IgG to HSV proteins by Western blot.

Results: Seven women were HSV seronegative, 14 HSV-1 seropositive, and 14 HSV-2 ± HSV-1 seropositive. Minimal changes in the serum anti-HSV profiles were seen over the 3 visits. The total cervical IgA, IgG, and protein levels did not change between the 2 pregnancy visits but tended to increase at the postpartum visit. No consistent change in cervical HSV-specific IgA and IgG was seen during pregnancy, but the levels increased markedly at the postpartum visit.

Conclusions: Lower cervical anti-HSV antibody levels may be related to the previously reported increased frequency of a reactivation of HSV during late pregnancy. Further evaluation is necessary to confirm and quantify the changes in genital immunity during pregnancy and to evaluate whether the increased levels at the postpartum visit are sustained.

Full Text

The Full Text of this article is available as a PDF (821.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ashley R. L., Corey L., Dalessio J., Wilson P., Remington M., Barnum G., Trethewey P. Protein-specific cervical antibody responses to primary genital herpes simplex virus type 2 infections. J Infect Dis. 1994 Jul;170(1):20–26. doi: 10.1093/infdis/170.1.20. [DOI] [PubMed] [Google Scholar]
  2. Ashley R. L., Corey L. Effect of acyclovir treatment of primary genital herpes on the antibody response to herpes simplex virus. J Clin Invest. 1984 Mar;73(3):681–688. doi: 10.1172/JCI111260. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Ashley R. L., Dalessio J., Burchett S., Brown Z., Berry S., Mohan K., Corey L. Herpes simplex virus-2 (HSV-2) type-specific antibody correlates of protection in infants exposed to HSV-2 at birth. J Clin Invest. 1992 Aug;90(2):511–514. doi: 10.1172/JCI115888. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Ashley R., Mack K., Critchlow C., Shurtleff M., Corey L. Differential effect of systemic acyclovir treatment of genital HSV-2 infections on antibody responses to individual HSV-2 proteins. J Med Virol. 1988 Mar;24(3):309–319. doi: 10.1002/jmv.1890240308. [DOI] [PubMed] [Google Scholar]
  5. Ashley R., Wald A., Corey L. Cervical antibodies in patients with oral herpes simplex virus type 1 (HSV-1) infection: local anamnestic responses after genital HSV-2 infection. J Virol. 1994 Aug;68(8):5284–5286. doi: 10.1128/jvi.68.8.5284-5286.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Baker D. A., Thomas J., Epstein J., Possilico D., Stone M. L. The effect of prostaglandins on the multiplication and cell-to-cell spread of herpes simplex virus type 2 in vitro. Am J Obstet Gynecol. 1982 Oct 1;144(3):346–349. doi: 10.1016/0002-9378(82)90589-0. [DOI] [PubMed] [Google Scholar]
  7. Brown Z. A., Benedetti J., Ashley R., Burchett S., Selke S., Berry S., Vontver L. A., Corey L. Neonatal herpes simplex virus infection in relation to asymptomatic maternal infection at the time of labor. N Engl J Med. 1991 May 2;324(18):1247–1252. doi: 10.1056/NEJM199105023241804. [DOI] [PubMed] [Google Scholar]
  8. Brown Z. A., Vontver L. A., Benedetti J., Critchlow C. W., Hickok D. E., Sells C. J., Berry S., Corey L. Genital herpes in pregnancy: risk factors associated with recurrences and asymptomatic viral shedding. Am J Obstet Gynecol. 1985 Sep 1;153(1):24–30. doi: 10.1016/0002-9378(85)90584-8. [DOI] [PubMed] [Google Scholar]
  9. Bryson Y., Dillon M., Bernstein D. I., Radolf J., Zakowski P., Garratty E. Risk of acquisition of genital herpes simplex virus type 2 in sex partners of persons with genital herpes: a prospective couple study. J Infect Dis. 1993 Apr;167(4):942–946. doi: 10.1093/infdis/167.4.942. [DOI] [PubMed] [Google Scholar]
  10. Coughlan B. M., Skinner G. R. Antibody activity to type 1 and type 2 herpes simplex virus in human cervical mucus. Br J Obstet Gynaecol. 1977 Aug;84(8):622–629. doi: 10.1111/j.1471-0528.1977.tb12666.x. [DOI] [PubMed] [Google Scholar]
  11. Dalessio J., Ashley R. Highly sensitive enhanced chemiluminescence immunodetection method for herpes simplex virus type 2 Western immunoblot. J Clin Microbiol. 1992 Apr;30(4):1005–1007. doi: 10.1128/jcm.30.4.1005-1007.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Frenkel L. M., Garratty E. M., Shen J. P., Wheeler N., Clark O., Bryson Y. J. Clinical reactivation of herpes simplex virus type 2 infection in seropositive pregnant women with no history of genital herpes. Ann Intern Med. 1993 Mar 15;118(6):414–418. doi: 10.7326/0003-4819-118-6-199303150-00003. [DOI] [PubMed] [Google Scholar]
  13. Grönroos M., Honkonen E., Terho P., Punnonen R. Cervical and serum IgA and serum IgG antibodies to Chlamydia trachomatis and herpes simplex virus in threatened abortion: a prospective study. Br J Obstet Gynaecol. 1983 Feb;90(2):167–170. doi: 10.1111/j.1471-0528.1983.tb08903.x. [DOI] [PubMed] [Google Scholar]
  14. Koutsky L. A., Stevens C. E., Holmes K. K., Ashley R. L., Kiviat N. B., Critchlow C. W., Corey L. Underdiagnosis of genital herpes by current clinical and viral-isolation procedures. N Engl J Med. 1992 Jun 4;326(23):1533–1539. doi: 10.1056/NEJM199206043262305. [DOI] [PubMed] [Google Scholar]
  15. Kulhanjian J. A., Soroush V., Au D. S., Bronzan R. N., Yasukawa L. L., Weylman L. E., Arvin A. M., Prober C. G. Identification of women at unsuspected risk of primary infection with herpes simplex virus type 2 during pregnancy. N Engl J Med. 1992 Apr 2;326(14):916–920. doi: 10.1056/NEJM199204023261403. [DOI] [PubMed] [Google Scholar]
  16. Merriman H., Woods S., Winter C., Fahnlander A., Corey L. Secretory IgA antibody in cervicovaginal secretions from women with genital infection due to herpes simplex virus. J Infect Dis. 1984 Apr;149(4):505–510. doi: 10.1093/infdis/149.4.505. [DOI] [PubMed] [Google Scholar]
  17. Murphy J. F., Murphy D. F., Barker S., Mylotte M. L., Coughlan B. M., Skinner G. R. Neutralising antibody against type 1 and type 2 herpes simplex virus in cervical mucus of women with cervical intra-epithelial neoplasia. Med Microbiol Immunol. 1985;174(2):73–80. doi: 10.1007/BF02123228. [DOI] [PubMed] [Google Scholar]
  18. Ostensen M., Lundgren R., Husby G., Rekvig O. P. Studies on humoral immunity in pregnancy: immunoglobulins, alloantibodies and autoantibodies in healthy pregnant women and in pregnant women with rheumatoid disease. J Clin Lab Immunol. 1983 Jul;11(3):143–147. [PubMed] [Google Scholar]
  19. Persson E., Eneroth P., Jeansson S. Secretory IgA against herpes simplex virus in cervical secretions. Genitourin Med. 1988 Dec;64(6):373–377. doi: 10.1136/sti.64.6.373. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Prober C. G., Sullender W. M., Yasukawa L. L., Au D. S., Yeager A. S., Arvin A. M. Low risk of herpes simplex virus infections in neonates exposed to the virus at the time of vaginal delivery to mothers with recurrent genital herpes simplex virus infections. N Engl J Med. 1987 Jan 29;316(5):240–244. doi: 10.1056/NEJM198701293160503. [DOI] [PubMed] [Google Scholar]
  21. Stern J. E., Wira C. R. Progesterone regulation of secretory component (SC): uterine SC response in organ culture following in vivo hormone treatment. J Steroid Biochem. 1988;30(1-6):233–237. doi: 10.1016/0022-4731(88)90098-2. [DOI] [PubMed] [Google Scholar]
  22. Sullender W. M., Yasukawa L. L., Schwartz M., Pereira L., Hensleigh P. A., Prober C. G., Arvin A. M. Type-specific antibodies to herpes simplex virus type 2 (HSV-2) glycoprotein G in pregnant women, infants exposed to maternal HSV-2 infection at delivery, and infants with neonatal herpes. J Infect Dis. 1988 Jan;157(1):164–171. doi: 10.1093/infdis/157.1.164. [DOI] [PubMed] [Google Scholar]
  23. Weinberg E. D. Pregnancy-associated depression of cell-mediated immunity. Rev Infect Dis. 1984 Nov-Dec;6(6):814–831. doi: 10.1093/clinids/6.6.814. [DOI] [PubMed] [Google Scholar]

Articles from Infectious Diseases in Obstetrics and Gynecology are provided here courtesy of Wiley

RESOURCES